Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age

被引:31
|
作者
Scheltens, Tjarda [1 ]
Verschuren, W. M. Monique [2 ]
Boshuizen, Hendriek C. [2 ]
Hoes, Arno W. [1 ]
Zuithoff, Nicolaas P. [1 ]
Bots, Michiel L. [1 ]
Grobbee, Dederick E. [1 ]
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands
[2] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
关键词
cardiovascular diseases; cohort studies; forecasting; risk factors;
D O I
10.1097/HJR.0b013e3283063a65
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The Framingham Heart Study risk model has been used in the majority of cardiovascular risk management guidelines. Recently, a new model based on the SCORE system has been proposed. We compared both risk models with regard to their ability to predict cardiovascular mortality in the Netherlands. Design Cohort study. Methods In a Dutch cohort study of 39 719 persons, three properties of the risk models were investigated: discriminating ability (ranking persons in order of risks, expressed in area under the curve); calibrating ability (prediction of events compared with actual events expressed in goodness of fit); and the number of persons assigned to treatment according to the guideline. Results The discriminative ability of both models was similar: the area under the curve of Framingham was 0.86 and of SCORE 0.85. Calibration of both functions was inadequate. The goodness of fit of the SCORE model was 35 and of the Framingham model 64, whereas a goodness of fit less than 20 is considered acceptable. Using the Dutch guideline treatment threshold of 10% mortality risk, the SCORE risk function assigned 0.4% of the population to drug treatment where the Framingham function assigned 0.7%. Conclusion The findings of this study show that both the SCORE and the Framingham model function have a good discriminative ability but are insufficient in predicting absolute risks. SCORE assigned fewer participants to treatment than Framingham. If a new risk model is implemented in treatment guidelines, comparison with the model in use and evaluation of calibrating features is needed. Eur J Cardiovasc Prev Rehabil 15:562-566 (C) 2008 The European Society of Cardiology
引用
收藏
页码:562 / 566
页数:5
相关论文
共 50 条
  • [1] Cardiovascular risk estimation: Comparison between different scoring systems (Framingham, Cuore and score)
    Milan, A.
    Movio, L.
    Tosello, F.
    Viola, A.
    Saglio, E.
    Rabbia, F.
    Mulatero, P.
    Veglio, F.
    [J]. JOURNAL OF HYPERTENSION, 2008, 26 : S97 - S98
  • [2] 2.16 ‘Framingham Score’ and ‘Progetto Cuore’: Comparison Between Cardiovascular Risk Score
    A. Milan
    L. Movio
    F. Tosello
    M. I. De Andres
    S. Monticone
    E. Saglio
    A. Viola
    F. Rabbia
    G. Papotti
    P. Mulatero
    F. Veglio
    [J]. High Blood Pressure & Cardiovascular Prevention, 2007, 14 (3) : 145 - 145
  • [3] Comparison of the Framingham Risk Score, SCORE, and UKPDS Risk Engine for Predicting Cardiovascular Disease Complications in People with Diabetes
    Ho, Joyce C.
    Staimez, Lisa R.
    Narayan, K. M. Venkat
    Simpson, Roy L.
    Hertzberg, Vicki S.
    [J]. DIABETES, 2019, 68
  • [4] Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome
    Jahangiry, Leila
    Farhangi, Mahdieh Abbasalizad
    Rezaei, Fatemeh
    [J]. JOURNAL OF HEALTH POPULATION AND NUTRITION, 2017, 36
  • [5] Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome
    Leila Jahangiry
    Mahdieh Abbasalizad Farhangi
    Fatemeh Rezaei
    [J]. Journal of Health, Population and Nutrition, 36
  • [6] IS ANKLE BRACHIAL INDEX AND FRAMINGHAM RISK SCORE A PREDICTOR OF CARDIOVASCULAR DISEASES IN PEOPLE AGED ≥50 YEARS?
    Celik, Hasan Huseyin
    Kutlu, Ruhusen
    Civi, Selma
    [J]. TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2013, 16 (02): : 142 - 149
  • [7] THE FRAMINGHAM RISK SCORE: ESTIMATION OF CARDIOVASCULAR RISK IN 1007 HEART TRANSPLANTS RECIPIENTS
    Bara, C.
    Zuckermann, A.
    Eisen, H.
    Karpov, A.
    Kobashigawa, J.
    Lehmkuhl, H. B.
    Ross, H.
    Schwende, H.
    Junge, G.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 10 - 10
  • [8] A computer tool for cardiovascular risk estimation according to Framingham and SCORE equations
    Ramirez-Rodrigo, Jesus
    Antonio Moreno-Vazquez, Jose
    Ruiz-Villaverde, Alberto
    Angeles Sanchez-Caravaca, Maria
    Lopez de la Torre-Casares, Martin
    Villaverde-Gutierrez, Carmen
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2013, 19 (02) : 277 - 284
  • [9] Comparison of the SCORE and Framingham-REGICOR funtions for cardiovascular risk assesment
    Ramos, Rafael
    Solanos, Pascual
    Subirana, Isaac
    Vila, Joan
    [J]. MEDICINA CLINICA, 2007, 128 (12): : 477 - 478
  • [10] Ten years cardiovascular risk estimation according to Framingham score and non HDL-cholesterol in blood donors
    Mabel Nora, Graffigna
    Gabriela, Berg
    Marta, Migliano
    Pablo, Salgado
    Jimena, Soutelo
    Carla, Musso
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2015, 9 (01) : 24 - 27